Koffiekamer « Terug naar discussie overzicht

Swingtrades in reguliere bedrijven

5.451 Posts, Pagina: « 1 2 3 4 5 6 ... 81 82 83 84 85 86 87 88 89 90 91 ... 269 270 271 272 273 » | Laatste
[verwijderd]
0
quote:

crackedtooth schreef op 19 april 2011 21:26:

MNKD 3.68 annotated chart

stockcharts.com/h-sc/ui?s=MNKD&p=...

FCSC nu 1,10 trouwens en flink stuk gelocked
MNKD 4,18
[verwijderd]
0
ProtoKinetix Forms Joint Venture Partnership to Launch a Dermatitis Therapeutic Product for the Skin Care Industry <PKTX.OB><PKTXE.OB>

pdf.reuters.com/htmlnews/8knews.asp?i...

VANCOUVER, British Columbia--(Business Wire)--
ProtoKinetix (OTCBB: PKTX) (www.protokinetix.com), is pleased to announce, that
it has entered into a Joint Venture Agreement with Imaginative Research
Associates, Inc. to formulate a topical anti-inflammation product for the skin
care market. Over the last 23-years Imaginative Research Associates, Inc. has
successfully partnered with several large pharmaceutical dermatology and
cosmetic companies and has licensed out patents and know-how to launch many
leading products in the skin care arena. Naomi Vishnupad, Ph.D., is the
President and COO of this Massachusetts based firm and has over 10-years of
experience in the pharmaceutical industry in all areas of drug development. She
has held positions in both big pharma, such as Wyeth Pharmaceuticals and
Bristol-Myers Squibb, and small biotech companies. Naomi holds a Ph.D. and M.S.
in immunology and a B.S. in biology.

Upon completion of this formulation, the Joint Venture will be able to offer a
topical preparation to specifically address skin conditions caused by
inflammation. Conditions such as dermatitis, psoriasis and eczema are often
treated with applications of corticosteroids or immune modulators, both of which
carry inherent, long term health risks. ProtoKinetix` AAGP has consistently
demonstrated powerful anti-inflammatory properties without toxic side effects.
The formulation and development of this therapeutic product line will offer hope
for an effective prescription and over the counter preparations to combat these
chronic inflammation causing diseases, while eliminating potential risks from
many of the current front line treatments.

Naomi Vishnupad stated that "There is a great need for new topical
anti-inflammatory treatments to treat a wide variety of skin conditions, such as
atopic dermatitis, eczema, and psoriasis. Many of the available treatments have
some undesirable side effects, and new therapeutic treatments would be
considered an advancement in dermatology". ProtoKinetix` President and CEO, Ross
Senior comments that "This Joint Venture supports ProtoKinetix` pursuit of AAGP
products for markets looking for safe and effective solutions to diseases and
conditions caused by chronic inflammation and immune response deficiencies."
[verwijderd]
0
OXGN 1.90.. mooi (entry 1.70)
ZSL lekker weer boven 15$ , 2e entry 13.40 na exiut 15$
[verwijderd]
0
quote:

crackedtooth schreef op 2 mei 2011 21:02:

OXGN 1.90.. mooi (entry 1.70)
ZSL lekker weer boven 15$ , 2e entry 13.40 na exiut 15$
OXGN 5.13 ... bijna balen dat ik vrij snel verkocht had
[verwijderd]
0
quote:

crackedtooth schreef op 11 mei 2011 17:40:

FEED 1.26 gap closed en bullish candle formation
Hoi Crack. Weet je wat de reden is voor de enorme daling van FEED? Tegenvallende cijfers?
[verwijderd]
0
quote:

Indianenverhalen schreef op 11 mei 2011 21:24:

[...]

Hoi Crack. Weet je wat de reden is voor de enorme daling van FEED? Tegenvallende cijfers?
FEED 1.24 stopped out gister, 1.25 had wel moeten houden, wacht nu voor nieuwe entry

Nou FEED verliest nog geld en heeft in 2007/2008 overnames gedaan voor teveel geld, dat schrijven ze af, eerder ook teveel overhead kosten

dus als het goed gaat dan word feed een turnaround story, nieuwe ceo daarin positief maar word afwachten gister leek mooie candle formatie maar laatste minuten van de dag toch de 1.25 gebroken, dus ik wacht nu even verder op confirmatie, alleen kleine core gehouden, maar kans op verdere daling aanwezig nu, mogelijke targets 1,10 (zie weekly chart) 1 dollar of 90 cent
[verwijderd]
0

TAIPEI, Taiwan, May 23, 2011 /PRNewswire-Asia-FirstCall/ -- GigaMedia Limited (NASDAQ: GIGM) announced today
that its board of directors has approved a US$11 million share repurchase program of the company's common
stock.

Under the terms of the approved program, GigaMedia may purchase up to US$11 million worth of its issued and
outstanding shares beginning from June 1, 2011. The repurchases will be made from time to time on the open
market at prevailing market prices pursuant to a Rule 10b5-1 plan. The purchases will be made subject to
restrictions relating to volume, pricing and timing. The timing and extent of any purchases will depend upon
market conditions, the trading price of GigaMedia's shares and other factors.
5.451 Posts, Pagina: « 1 2 3 4 5 6 ... 81 82 83 84 85 86 87 88 89 90 91 ... 269 270 271 272 273 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
932,09  +2,31  +0,25%  26 feb
 Germany40^ 22.637,30 -0,69%
 BEL 20 4.476,06 +1,76%
 Europe50^ 5.489,33 -0,70%
 US30^ 43.479,60 0,00%
 Nasd100^ 21.165,60 0,00%
 US500^ 5.962,30 0,00%
 Japan225^ 38.073,10 0,00%
 Gold spot 2.916,96 +0,03%
 EUR/USD 1,0482 -0,30%
 WTI 68,75 -0,43%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

Alfen N.V. +6,43%
RANDSTAD NV +5,52%
ArcelorMittal +5,39%
Aperam +4,56%
Sif Holding +4,49%

Dalers

Wolters Kluwer -10,85%
RELX -2,42%
WDP -1,80%
PostNL -1,42%
CTP -1,22%